Osteotech’s Discontinued bio-d Bone Dowel Constituted About 3% Of Sales
This article was originally published in The Gray Sheet
Executive Summary
Osteotech will cease production of its bio-d threaded cortical bone dowel system by Jan. 31, 2003 under a patent infringement settlement with Medtronic's Sofamor Danek unit, announced April 30
You may also be interested in...
GenSci Seeking To Stay Injunction Of DynaGraft Gel, Putty Products
GenSci is planning to appeal a Los Angeles jury's $14.5 mil. damage award to Osteotech for patent infringement through the sale of its DynaGraft Gel and Putty bone products
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.